[Retroperitoneal fibrosis due to ergotamine. Apropos a case].

OBJECTIVES

This paper reviews retroperitoneal fibrosis secondary to ergotamine and evaluated the current tools in its diagnosis.

METHODS/

RESULTS

A well documented case of a young patient with retroperitoneal fibrosis resulting from chronic use of ergotic agents is presented. The fibrous plaque remitted after withdrawal of the causal agent.

CONCLUSIONS

The importance of contrast-enhanced CT in the diagnosis of retroperitoneal fibrosis is widely accepted. The usefulness of this technique in determining the extent of the lesion and for subsequent follow up is underscored.